Caprion-HistoGeneX Acquires Mosaic Laboratories
Acquiring Mosaic further strengthens the North American base for Caprion-HistoGeneX's histopathology assay development and deployment and expands the volume of pathology services.
Acquiring Mosaic further strengthens the North American base for Caprion-HistoGeneX's histopathology assay development and deployment and expands the volume of pathology services.
The latest Mastermind Genomic Search Engine includes Copy Number Variation search to accelerate diagnosis and genomic interpretation of results.
Monitoring cancer therapy in real time enables physicians to make smarter treatment decisions.
AI-driven digital pathology can accelerate cancer diagnosis and clinical trial recruitment.
The SCP-R is designed for use in pathology and histology labs to print high-resolution text, graphics, and bar codes directly onto tissue cassettes.
Stellaris is designed to significantly improve how scientists are able to capture three-dimensional images of living cells and tissues.
Analysis of cell-free DNA in blood samples is revolutionizing cancer treatment and prognosis.
Increased availability of such devices may help to facilitate continuity of patient care by preventing disruptions to critical pathology services.
The launch focuses on several immunooncology markers that are critical for early-stage cancer drug development and patient treatment.
The research focuses on a new method to process and immunolabel breast cancer core needle biopsies.